Free Trial

Humana (HUM) Competitors

Humana logo
$227.78 -2.89 (-1.25%)
As of 12:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

HUM vs. CI, CNC, ELV, MOH, UNH, SEM, JYNT, AEMD, MDT, and BMY

Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), UnitedHealth Group (UNH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), Medtronic (MDT), and Bristol Myers Squibb (BMY). These companies are all part of the "medical" sector.

Humana vs. Its Competitors

Cigna Group (NYSE:CI) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

Cigna Group has higher revenue and earnings than Humana. Humana is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$247.12B0.33$3.43B$18.0616.68
Humana$117.76B0.23$1.21B$14.1416.06

Cigna Group has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500.

Cigna Group pays an annual dividend of $6.04 per share and has a dividend yield of 2.0%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.6%. Cigna Group pays out 33.4% of its earnings in the form of a dividend. Humana pays out 25.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.7% of Cigna Group shares are owned by company insiders. Comparatively, 0.4% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Cigna Group had 9 more articles in the media than Humana. MarketBeat recorded 31 mentions for Cigna Group and 22 mentions for Humana. Cigna Group's average media sentiment score of 1.25 beat Humana's score of 0.68 indicating that Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
27 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
10 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group currently has a consensus target price of $380.39, suggesting a potential upside of 26.24%. Humana has a consensus target price of $280.76, suggesting a potential upside of 23.62%. Given Cigna Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cigna Group is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
2 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.00
Humana
0 Sell rating(s)
16 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.30

Cigna Group has a net margin of 1.97% compared to Humana's net margin of 1.42%. Cigna Group's return on equity of 18.63% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group1.97% 18.63% 4.97%
Humana 1.42%14.47%5.03%

Summary

Cigna Group beats Humana on 16 of the 19 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaMED IndustryMedical SectorNYSE Exchange
Market Cap$27.44B$40.91B$5.54B$20.64B
Dividend Yield1.53%101.64%5.06%3.71%
P/E Ratio16.088.9228.2927.82
Price / Sales0.230.76374.5355.14
Price / Cash9.668.9124.7217.94
Price / Book1.662.608.254.59
Net Income$1.21B$2.64B$3.19B$989.58M
7 Day Performance-4.17%-3.27%5.46%0.98%
1 Month Performance-3.30%-13.58%9.42%5.30%
1 Year Performance-40.58%-35.21%30.15%10.40%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HUM
Humana
4.529 of 5 stars
$227.78
-1.3%
$280.76
+23.3%
-39.7%$27.47B$117.76B16.1065,680Analyst Downgrade
CI
Cigna Group
4.9985 of 5 stars
$312.06
-2.4%
$380.39
+21.9%
-9.6%$83.36B$247.12B17.2873,500Positive News
CNC
Centene
4.9789 of 5 stars
$33.20
-0.3%
$68.87
+107.5%
-53.7%$16.52B$163.07B4.9560,500Trending News
Analyst Forecast
High Trading Volume
ELV
Elevance Health
4.9608 of 5 stars
$346.59
-0.4%
$498.87
+43.9%
-36.5%$78.30B$177.01B13.52104,200Upcoming Earnings
Analyst Forecast
MOH
Molina Healthcare
4.9879 of 5 stars
$233.33
-2.6%
$364.21
+56.1%
-24.7%$12.65B$40.65B11.2718,000Analyst Forecast
UNH
UnitedHealth Group
4.997 of 5 stars
$303.39
-1.7%
$415.57
+37.0%
-40.6%$275.22B$400.28B12.70400,000Positive News
Upcoming Earnings
SEM
Select Medical
5 of 5 stars
$14.93
-1.4%
$26.00
+74.2%
-60.7%$1.92B$5.19B11.1444,100
JYNT
Joint
3.3351 of 5 stars
$11.87
+1.5%
$15.50
+30.6%
-15.8%$181.53M$51.90M-20.46320
AEMD
Aethlon Medical
1.8876 of 5 stars
$1.16
-6.9%
$56.00
+4,748.5%
-65.3%$2.99M$570K-0.0910
MDT
Medtronic
4.5954 of 5 stars
$87.52
-1.0%
$97.87
+11.8%
+15.5%$112.25B$33.54B24.1895,000Positive News
Analyst Forecast
BMY
Bristol Myers Squibb
4.884 of 5 stars
$46.51
-0.9%
$58.00
+24.7%
+15.9%$94.64B$48.30B17.4234,100Analyst Revision

Related Companies and Tools


This page (NYSE:HUM) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners